JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crutchley, D. J.
Right arrow Articles by Ryan, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crutchley, D. J.
Right arrow Articles by Ryan, J. W.

Glucocorticoid modulation of prostacyclin production in cultured bovine pulmonary endothelial cells

DJ Crutchley, US Ryan and JW Ryan

The present study has examined the ability of glucocorticoids to modify the production of prostacyclin by endothelial cells derived from bovine pulmonary arteries. Binding studies with [3H]dexamethasone indicated that these cells possessed high-affinity binding sites for glucocorticoids (Kd approximately 4 nM). The cells released prostacyclin, measured serologically as its hydrolysis product 6-keto- prostaglandin F1 alpha. The release was strongly stimulated by a 5-min incubation with 50 nM bradykinin, 2 microM calcium ionophore A23187 or 1 to 5 microM arachidonic acid. Dexamethasone, 1 to 20 nM, suppressed prostacyclin release in response to bradykinin and ionophore in a dose- dependent manner. The suppressive effects required 24 hr for full expression. Maximal inhibition of bradykinin-induced prostacyclin release was approximately 65% and that of ionophore-induced release was approximately 35%. Total inhibition was not observed. Hydrocortisone at 20 nM inhibited bradykinin-induced release of prostacyclin by approximately 45% but had no effect on ionophore-induced release. Neither glucocorticoid inhibited prostacyclin release in response to arachidonic acid. Triton X-100 extracts and conditioned media from cells treated with 20 nM dexamethasone failed to modify prostacyclin release when added to fresh endothelial cells. We conclude that dexamethasone, in concentrations likely to produce virtually complete binding site occupancy, inhibits agonist-induced release of prostacyclin from bovine pulmonary endothelial cells. Inhibition appears to occur at the level of intracellular arachidonic acid release. However, we have been unable to obtain definitive evidence for the production of a macromolecular phospholipase inhibitor by endothelial cells in response to these low concentrations of steroid.

Volume 233, Issue 3, pp. 650-655, 06/01/1985
Copyright © 1985 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
P. Collin-Osdoby, L. Rothe, F. Anderson, M. Nelson, W. Maloney, and P. Osdoby
Receptor Activator of NF-kappa B and Osteoprotegerin Expression by Human Microvascular Endothelial Cells, Regulation by Inflammatory Cytokines, and Role in Human Osteoclastogenesis
J. Biol. Chem., June 1, 2001; 276(23): 20659 - 20672.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1985 by the American Society for Pharmacology and Experimental Therapeutics.